home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

21st Annual Drug Discovery and 8th Annual Drug Design & Medicinal Chemistry Congress

 
  November 27, 2019  
     
 
Oxford Global, Maritim Hotel Berlin, Stauffenbergstraße 26, 10785, Berlin, Germany
26 - 27 May 2020


 

Join over 400 leaders, experts and scientists at the renowned R&D Series, helping to shape the future of drug discovery and development at Oxford Global’s 20th Annual Drug Discovery Summit and 7th Annual Discovery Chemistry and Drug Design Congress, 26th  – 27th May 2020, Berlin, Germany. 

 


The events are aimed at VPs and senior directors of discovery in biology and chemistry from global pharmaceutical and biotech organisations. New for 2020, the event features focused R&D leaders sessions on Drug discovery Modalities and AI in drug development. It will also highlights successful strategies in delivering On Target Discovery, Phenotypic/Crispr Screening, Applications Of Organ-In-A Chip Platforms As Well As Tissue And 3D Culture For Disease Modelling. Empowering Drug Discovery with Chemical Biology, senior experts will also learn about enabling technologies that facilitate quicker drug development timelines such as protein degradation tools, target-based discovery techniques including RNA as novel targets. Do not miss out on cutting edge insights into computational chemistry and drug design methods. 


Key opinion leaders joining our events include: 

 

Steve Rees, Vice President Discovery Biology, AstraZeneca R&D Biopharmaceuticals Discovery Sciences 

Ulrich A.K. Betz, Vice President Innovation, Department Head Future Insight, Merck KGaA 

Thorsten Thormann, Vice President, Research, LEO Pharma 

Alex Gouliaev, Vice President, Amgen 

Michael R. Myers, Senior Director, LRL - Due Diligence, Eli Lilly and Company 

Oliver Rausch, CSO, Storm Therapeutics 

 

The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion 

 

These events form part of the R&D Series EU and are co-located with our 2nd Annual Neuroscience in Discovery & Development Congresses.

 

View the Agenda: https://bit.ly/34wMgmE 


For more information contact g.alonso@oxfordglobal.co.uk or visit the website: https://bit.ly/33r8ULN 

 


 

Go Social: Join our Drug Discovery & Development Network on LinkedIn, follow us on Twitter @drugdiscovery1 and  & join the conversation at #RNDSeries20

 

 
 
Organized by: OxfordGlobal
Invited Speakers:

Steve Rees, Vice President Discovery Biology, AstraZeneca R&D Biopharmaceuticals Discovery Sciences 

 

Ulrich A.K. Betz, Vice President Innovation, Department Head Future Insight, Merck KGaA 

 

Thorsten Thormann, Vice President, Research, LEO Pharma 

 

Alex Gouliaev, Vice President, Amgen 

 

Michael R. Myers, Senior Director, LRL - Due Diligence, Eli Lilly and Company 

 

Oliver Rausch, CSO, Storm Therapeutics 

 
Deadline for Abstracts: N/A
 
Registration: https://bit.ly/2L0a0aT
E-mail: g.alonso@oxfordglobal.co.uk
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.